WHO世界卫生组织：2025年关于保护婴儿免受呼吸道合胞病毒病侵害的免疫接种立场文件报告（英文版）

Recommendations on the use of maternal respiratory syncytial virus (RSV) vaccines and long-acting RSV monoclonal antibodies (mAbs) to prevent severe RSV disease in infants were issued by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization in September 2024 and endorsed by WHO thereafter. Evidence presented at that meeting, as well as SAGE’s conflict-of-interest assessment, can be accessed online. Separate policy recommendations on RSV vaccination for older adults will be issued